QS 21 [clinicaltrials_resource:8629374b0f681947a17dbc4505d6eb82]
A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy Adults [clinicaltrials:NCT00000853]A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults. [clinicaltrials:NCT00001044]A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults [clinicaltrials:NCT00001052]A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 MN rsgp120 and Bivalent AIDSVAX B/E (HIV-1 MN rgp120/A244 rgp120) in Combination With QS-21 With or Without Alum in Healthy HIV-1 Uninfected Adults [clinicaltrials:NCT00001096]clinicaltrials:NCT00003224Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease [clinicaltrials:NCT00003357]clinicaltrials:NCT00003819clinicaltrials:NCT00004156Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy [clinicaltrials:NCT00004249]clinicaltrials:NCT00004929clinicaltrials:NCT00005632Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00006041]clinicaltrials:NCT00036933clinicaltrials:NCT00470574clinicaltrials:NCT00479557clinicaltrials:NCT00498602clinicaltrials:NCT00752232clinicaltrials:NCT00955409clinicaltrials:NCT00959192A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease [clinicaltrials:NCT00960531]clinicaltrials:NCT01227564Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes [clinicaltrials:NCT01687595]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
QS 21 [clinicaltrials_resource:8629374b0f681947a17dbc4505d6eb82]
Bio2RDF identifier
8629374b0f681947a17dbc4505d6eb82
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8629374b0f681947a17dbc4505d6eb82
identifier
clinicaltrials_resource:8629374b0f681947a17dbc4505d6eb82
title
QS 21
@en
type
label
QS 21 [clinicaltrials_resource:8629374b0f681947a17dbc4505d6eb82]
@en